Non-cytotoxic Concentration of Cisplatin Decreases Neuroplasticity-Related Proteins and Neurite Outgrowth Without Affecting the Expression of NGF in PC12 Cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurochemical Research

• Publication date

  2016-07-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11064-016-2019-5PMID 27473385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?

  2015cited by this paper
• Treatment of Chronic Pain by Integrative Approaches

  2015cited by this paper
• Caffeic acid phenethyl ester (CAPE) protects PC12 cells from MPP+ toxicity by inducing the expression of neuron-typical proteins.

  2014cited by this paper
• Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy

  2014cited by this paper
• Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease

  2014cited by this paper
• Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

  2013cited by this paper
• Neuroplasticity, Sensitization, and Pain

  2013cited by this paper
• Cancer Chemotherapy-Induced Neuropathic Pain: The Underlying Peripheral Neuropathy

  2012cited by this paper
• In vitro neurotoxicology: an introduction.

  2011cited by this paper
• ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA

  2011cited by this paper
• Neurotoxicity Caused by the Treatment with Platinum Analogues

  2011cited by this paper
• Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons.

  2011cited by this paper
• Quantitative assessment of neurite outgrowth in PC12 cells.

  2011cited by this paper
• The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.

  2010cited by this paper
• Oxidative stress from diverse developmental neurotoxicants: antioxidants protect against lipid peroxidation without preventing cell loss.

  2010cited by this paper
• Plasticity and regeneration in the peripheral nervous system.

  2010cited by this paper
• Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered.

  2010cited by this paper
• Persistent neuropathy after treatment with cisplatin and oxaliplatin

  2009cited by this paper
• Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model

  2007cited by this paper
• Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.

  2006cited by this paper
• Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.

  2006cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Chemotherapy-induced peripheral neuropathy.

  2005cited by this paper
• Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.

  2005cited by this paper
• Platinum-based chemotherapy in metastatic breast cancer: current status.

  2004cited by this paper
• The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.

  2004cited by this paper
• Oxaliplatin‐induced neurotoxicity: Acute hyperexcitability and chronic neuropathy

  2004cited by this paper
• Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures.

  2004cited by this paper
• Neurofilament 200 as an Indicator of Differences Between Mipafox and Paraoxon Sensitivity in SY5Y Neuroblastoma Cells

  2004cited by this paper
• Oxaliplatin-safety profile: neurotoxicity.

  2003cited by this paper
• Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.

  2003cited by this paper
• Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor.

  2002cited by this paper
• Chemotherapy-induced peripheral neuropathy

  2002cited by this paper
• Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis.

  2000influential reference
• Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?

  2000cited by this paper
• Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.

  2000cited by this paper
• Upregulation of B50/GAP‐43 protein mRNA in rat dorsal root ganglia during cisplatin intoxication

  1996cited by this paper
• TrkC Isoforms with Inserts in the Kinase Domain Show Impaired Signaling Responses (*)

  1996cited by this paper
• Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

  1989cited by this paper
• Sensory Neuronopathy

  1987cited by this paper
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

  1976cited by this paper
• crosstalk: Therapeutical relevance for

  year unknowncited by this paper

• Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure

  2025cites this paper
• RNA-seq revealed the protective effect of Huangqi Guizhi Wuwu Decoction against cisplatin induced PC12 cell injury

  2024cites this paper
• Investigation of effects of quercetin and low-level laser therapy in cisplatin-induced in vitro peripheral neuropathy model

  2023cites this paper
• Arc-Mediated Synaptic Plasticity Regulates Cognitive Function in a Migraine Mouse Model

  2023cites this paper
• Interferon-beta induces major histocompatibility complex of class I (MHC-I) expression and a proinflammatory phenotype in cultivated human astrocytes.

  2022cites this paper
• Neuron Compatibility and Antioxidant Activity of Barium Titanate and Lithium Niobate Nanoparticles

  2022cites this paper
• Cisplatin-induced changes in calcitonin gene-related peptide or TNF-α release in rat Dorsal Root Ganglia in vitro model of neurotoxicity are not reverted by rosiglitazone.

  2022cites this paper
• Implantable Drug Reservoir Devices for Inner Ear Delivery of Pharmacotherapeutics

  2020cites this paper
• Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents.

  2019cites this paper
• Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells Against Cisplatin-Induced Neurotoxicity by Activating the AMPK/SIRT1, MAPK/Erk, and PI3k/Akt Signaling Pathways

  2019cites this paper
• Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells from Cisplatin-Induced Neurotoxicity by Activating the NGF-Signaling Pathway

  2018cites this paper
• Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells from Cisplatin-Induced Neurotoxicity by Activating the NGF-Signaling Pathway

  2017cites this paper